Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Cancer.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2005 by Nanjing Medical University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Nanjing Medical University
ClinicalTrials.gov Identifier:
NCT00251563
First received: November 9, 2005
Last updated: October 12, 2006
Last verified: November 2005
  Purpose

Environmental and genetic factors may play a role in the progression of cancer. The goal of this project is to establish a series of cross-sectional / case-control studies to evaluate risk factors of cancer in China.


Condition
Cancer

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Nanjing Medical University:

Study Start Date: August 2005
Detailed Description:

This study is designed to investigate the epidemiologic, genetic, laboratory and clinical characterization of individuals with cancer (gastric, colorectal, esophageal, liver, prostate, lung, breast and endometrial cancer, etc.). We will accrue approximately 1600 patients as experimental group. The control group consists of subjects who will be confirmed without cancer. We will explore the environmental (including family history, life style, diet, physical activity, neuropsychological functioning,plasma levels of oxidative stress factors, angiogenic factors, and tumor markers, etc.) and genetic (including oxidative stress factors and angiogenic factors, etc.) risk factors. We will study the association between various environmental risk factors with the clinical characterization and correlation between the genetic polymorphisms and the presence of various cancer.

  Eligibility

Ages Eligible for Study:   18 Years to 89 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • This is a study only of Chinese. Subjects will be allowed to participate if they self-identify as Chinese. The age range of the participants will be between 18 and 89 years. Individuals with cancer (gastric, colorectal, esophageal, liver, prostate, lung, breast and endometrial cancer, etc.) will be allowed to participate. To participate in the study as the control, subjects should be confirmed without cancer.

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00251563

Contacts
Contact: Bin Wang, Ph.D 0086-25-86862884 binwang@njmu.edu.cn

Locations
China, Jiangsu
Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University Recruiting
Nanjing, Jiangsu, China, 210029
Contact: Bin Wang, Ph.D    0086-25-86862884    binwang@njmu.edu.cn   
Sponsors and Collaborators
Nanjing Medical University
Investigators
Principal Investigator: Bin Wang, Ph.D Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00251563     History of Changes
Other Study ID Numbers: ICP036
Study First Received: November 9, 2005
Last Updated: October 12, 2006
Health Authority: China: Ethics Committee

Keywords provided by Nanjing Medical University:
Cancer,Risk factors

ClinicalTrials.gov processed this record on September 30, 2014